Cargando…
Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511082/ https://www.ncbi.nlm.nih.gov/pubmed/35856458 http://dx.doi.org/10.1111/jvim.16490 |
_version_ | 1784797584816078848 |
---|---|
author | Saba, Corey |
author_facet | Saba, Corey |
author_sort | Saba, Corey |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9511082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95110822022-09-30 Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” Saba, Corey J Vet Intern Med Letters to the Editor John Wiley & Sons, Inc. 2022-07-20 2022 /pmc/articles/PMC9511082/ /pubmed/35856458 http://dx.doi.org/10.1111/jvim.16490 Text en © 2022 The Author. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC. on behalf of the American College of Veterinary Internal Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letters to the Editor Saba, Corey Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” |
title | Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” |
title_full | Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” |
title_fullStr | Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” |
title_full_unstemmed | Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” |
title_short | Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” |
title_sort | response to letter regarding “alvac‐fil2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: a pilot study” |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511082/ https://www.ncbi.nlm.nih.gov/pubmed/35856458 http://dx.doi.org/10.1111/jvim.16490 |
work_keys_str_mv | AT sabacorey responsetoletterregardingalvacfil2afelineinterleukin2immunomodulatorasatreatmentforsarcoidsinhorsesapilotstudy |